<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Tumoricidal activity of Soviet-synthesized oxoplatinum and cycloplatam was shown to influence human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> strains (<z:hpo ids='HP_0002861'>melanoma</z:hpo>, <z:e sem="disease" ids="C0740457" disease_type="Neoplastic Process" abbrv="">cancer of the kidney</z:e>, Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) transplanted to <z:mp ids='MP_0003815'>nude</z:mp> mice </plain></SENT>
<SENT sid="1" pm="."><plain>Their therapeutic effect was associated with <z:hpo ids='HP_0001888'>lymphopenia</z:hpo>; however, they did not suppress the chemically determined activity of succinate dehydrogenase and alpha-<z:chebi fb="0" ids="24346">glycerophosphate</z:chebi> dehydrogenase </plain></SENT>
</text></document>